A study for a 51 year old man who takes Trulicity, Metformin - from FDA reports


Summary

130 males aged 51 (±5) who take the same drugs are studied. This is a personalized study for a 51 year old male patient who has Insulin-Requiring Type Ii Diabetes Mellitus. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 11, 2017

130 males aged 51 (±5) who take Trulicity, Metformin are studied.


Number of reports submitted per year:

Trulicity, Metformin for a 51-year old man.

Information of the patient in this study:

  • Age: 51
  • Gender: male
  • Conditions: Insulin-Requiring Type Ii Diabetes Mellitus
  • Drugs taken:
    • Trulicity (dulaglutide)
    • Metformin (metformin hydrochloride)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Itching: 0 (0% of males aged 51 (±5) who take the drugs)
  • Rashes: 2 (1.54% of males aged 51 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  • nausea
  • diarrhea
  • fatigue
  • dizziness
  • muscle spasms
  • nausea and vomiting
  • appetite - decreased
  • abdominal pain upper
  • chest pain
  • cardiac failure congestive
1 - 6 months:
  • rash papulosquamous
  • pancreatitis
  • rectal haemorrhage
  • appetite - decreased
  • glycosylated haemoglobin increased
  • blood glucose increased
  • gingival bleeding
  • malaise
  • nosebleed
  • flatulence
6 - 12 months:
  • hypertriglyceridaemia
  • pancreatitis
  • rash vesicular
  • hepatic steatosis
1 - 2 years:
  • diabetic ketoacidosis
  • injection site pain
  • injection site bruising
  • amylase increased
  • pancreatic enzymes increased
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  • nausea
  • diarrhea
  • malaise
  • blood glucose increased
  • fatigue
  • injection site pain
  • blood glucose decreased
  • nausea and vomiting
  • appetite - decreased
  • neutrophil count increased

Top conditions involved for these people *:

  • High Blood Pressure (7 people, 5.38%)
  • Depression (4 people, 3.08%)
  • High Blood Cholesterol (3 people, 2.31%)
  • Multiple Sclerosis (2 people, 1.54%)
  • Blood Glucose Abnormal (2 people, 1.54%)

Top co-used drugs for these people *:

  • Humalog (12 people, 9.23%)
  • Invokana (10 people, 7.69%)
  • Lantus (8 people, 6.15%)
  • Actos (5 people, 3.85%)
  • Farxiga (4 people, 3.08%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Insulin-requiring type ii diabetes mellitus, Trulicity, Metformin, Rashes, Itching

You may be interested in these reviews

More reviews for: Insulin-requiring type ii diabetes mellitus, Trulicity, Metformin, Rashes, Itching